As of the latest Form 4 filed Jul 9, 2026.
What Medtronic PLC insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 37 most recent filings for MDT.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-09 | 2026-07-08 | Walter Matthew R. SVP, Chief HR Officer | SSale | −3.10K | $83.15 | $258K | Yes (planned) | Form 4 ↗ |
| 2026-06-09 | 2026-06-08 | KIIL HARRY SKIP EVP & President Cardiovascular | SSale | −228.00 | $80.45 | $18.3K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-08 | KIIL HARRY SKIP, EVP & President Cardiovascular | SSale | −3.96K | $80.44 | $319K | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | Blomquist Denise L. Chief Accounting Officer | FTax | −237.00 | $83.32 | $19.7K | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Walter Matthew R. SVP, Chief HR Officer | FTax | −2.84K | $83.32 | $237K | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Marinaro Michael EVP, Pres MedSurg and Americas | FTax | −7.47K | $83.32 | $622K | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | KIIL HARRY SKIP EVP & President Cardiovascular | FTax | −6.82K | $83.32 | $568K | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Martha Geoffrey Chairman and CEO | FTax | −41.9K | $83.32 | $3.49M | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Blomquist Denise L. Chief Accounting Officer | MExercise | +1.71K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Walter Matthew R. SVP, Chief HR Officer | MExercise | +9.15K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Marinaro Michael EVP, Pres MedSurg and Americas | MExercise | +19.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | KIIL HARRY SKIP EVP & President Cardiovascular | MExercise | +15.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Martha Geoffrey Chairman and CEO | MExercise | +95.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Wall Brett A. EVP & Pres Neuroscience | MExercise | +26.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | Walter Matthew R. SVP, Chief HR Officer | FTax | −35.00 | $80.00 | $2.80K | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | Blomquist Denise L. Chief Accounting Officer | FTax | −318.00 | $81.90 | $26.0K | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | Lewis Gregory P Director | FTax | −207.00 | $81.90 | $17.0K | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | NABEL ELIZABETH G Director | FTax | −207.00 | $81.90 | $17.0K | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | Lofton Kevin E Director | FTax | −207.00 | $81.90 | $17.0K | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | Fonseca Lidia Director | FTax | −207.00 | $81.90 | $17.0K | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | Powell Kendall J Director | FTax | −207.00 | $81.90 | $17.0K | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | DONNELLY SCOTT C Director | FTax | −207.00 | $81.90 | $17.0K | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | HOGAN RANDALL J Director | FTax | −207.00 | $81.90 | $17.0K | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | ARNOLD CRAIG Director | FTax | −207.00 | $81.90 | $17.0K | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Lee Joon Sup Director | AAward | +1.80K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Blomquist Denise L. Chief Accounting Officer | AAward | +1.51K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Lewis Gregory P Director | AAward | +2.11K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | NABEL ELIZABETH G Director | AAward | +2.11K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Groetelaars John P Director | AAward | +1.44K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Lofton Kevin E Director | AAward | +2.11K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Fonseca Lidia Director | AAward | +2.11K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Powell Kendall J Director | AAward | +2.11K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | DONNELLY SCOTT C Director | AAward | +2.11K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Jellison William R Director | AAward | +1.44K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | HOGAN RANDALL J Director | AAward | +2.11K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | ARNOLD CRAIG Director | AAward | +2.11K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-02 | 2026-01-29 | Blomquist Denise L. Chief Accounting Officer | FTax | −148.00 | $101.00 | $14.9K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also MDT’s full analysis or the market-wide insider trading feed. The tabs above jump to MDT’s other SEC data.
Source: SEC Form 4 filings for MDT, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.